Transmarket Holdings’s Cidara Therapeutics CDTX Stock Holding History

Transmarket Holdings’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,360	Closed	-$1.18M	–	41
2025 Q4	$1.18M	Buy	+5,360	New	+$866K	0.86%	21

Transmarket Holdings's CDTX Position: Q1 2026 in Review

Transmarket Holdings sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,360 shares — an estimated $1.18M sold.

Transmarket Holdings first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.18M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Transmarket Holdings reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Transmarket Holdings sold 5,360 Cidara Therapeutics shares in Q1 2026, an estimated $1.18M.
Transmarket Holdings first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Transmarket Holdings's Cidara Therapeutics position peaked at $1.18M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Transmarket Holdings's 13F filing for Q1 2026, filed 13 May 2026.